Herrmann K, Schulze E, Heckmann M, Schubert I, Meurer M, Ziegler V, Haustein U F, Mehlhorn J, Krieg T
Department of Dermatology, Karl-Marx-University, Leipzig, G.D.R.
Br J Dermatol. 1990 Jul;123(1):1-7. doi: 10.1111/j.1365-2133.1990.tb01818.x.
A group of 191 patients with systemic scleroderma and 12 patients with silicosis-associated scleroderma were investigated for connective tissue turnover. The serum levels of type III collagen aminopropeptide (P-III-P), the laminin PI (Lam PI) fragment and the acid lysosomal beta-galactosidase (beta-Gal) were determined by specific radioimmunoassays and spectrofluorometry, respectively. Increased levels of type III collagen aminopropeptide strongly correlated with enhanced activity of beta-galactosidase. Both parameters correlated with the clinical course in idiopathic systemic scleroderma and in silicosis-associated scleroderma. Serum levels of Lam PI were also found to be elevated in both groups, although there was no correlation with the severity of the disease. Autoantibodies directed against the DNA topoisomerase Scl-70 and against centromeric proteins were found in a similar range in patients with idiopathic systemic and silicosis-associated scleroderma. These results suggest that P-III-P, Lam PI and beta-Gal are useful serological markers of fibrotic activity and demonstrate similarities between idiopathic systemic scleroderma and scleroderma associated with silica-dust exposure.
对191例系统性硬化症患者和12例矽肺相关性硬化症患者进行了结缔组织更新情况的调查。分别通过特异性放射免疫测定法和荧光分光光度法测定了III型胶原氨基端前肽(P-III-P)、层粘连蛋白PI(Lam PI)片段和酸性溶酶体β-半乳糖苷酶(β-Gal)的血清水平。III型胶原氨基端前肽水平升高与β-半乳糖苷酶活性增强密切相关。这两个参数与特发性系统性硬化症和矽肺相关性硬化症的临床病程相关。两组患者的Lam PI血清水平也均升高,尽管与疾病严重程度无关。在特发性系统性硬化症患者和矽肺相关性硬化症患者中,抗DNA拓扑异构酶Scl-70和抗着丝粒蛋白的自身抗体水平范围相似。这些结果表明,P-III-P、Lam PI和β-Gal是纤维化活动的有用血清学标志物,并证明了特发性系统性硬化症与矽尘暴露相关性硬化症之间存在相似性。